Prehabilitation for Adults With End Stage Renal Disease on the Kidney Transplant Waitlist

Prehabilitation is the enhancement of functional capacity of a patient to improve their
ability to withstand a future stressor. The investigators primary objective is to demonstrate
feasibility for prehabilitation in Aim 1 and test whether the number of prehabilitation
sessions is associated with increased physical activity. The investigators will formally test
whether prehabilitation is associated with a reduction in short term and long term KT
outcomes as part of Aim 2. The investigators will test whether there is an effect of
prehabilitation on short-term (KT length of stay> 2 weeks, early hospital readmission and
delayed graft function) and long-term (acute rejection (within the first year), 1 year
patient and graft survival) outcomes compared to standard of care controls. Participants will
be followed for 3-6 months or until they receive a kidney transplant.

Inclusion Criteria:

1. Men and women with end stage renal disease who are within 3-6 months of kidney
transplantation and are on the kidney transplant waitlist at Johns Hopkins

2. Must be at least 18 years or older at enrollment

3. Must be English speaking

4. Must be enrolled in an ongoing cohort study of adults with ESRD who are being
evaluated for kidney transplantation

5. Must be willing to participate in a prehabilitation program and able to give informed
consent

Exclusion Criteria:

1. Patients who have any of the following medical conditions will be excluded from the
study:

- Active Angina pectoris

- Chronic lung disease and daily use of oxygen

- Cerebral vascular disease

- Musculoskeletal conditions that would limit participation in prehabilitation

- Lower- or upper-extremity amputation

- Orthopedic disorders exacerbated by physical activity

- Decreased mental capacity

2. Patients who live outside of Maryland will not be included in the study.